Pegylation increases platelet biocompatibility of gold nanoparticles

Journal of Biomedical Nanotechnology

Volumn 10, Issue 6, 2014, Pages 1004-1015

  Santos Martinez, Maria Jose ^a,b   Rahme, Kamil ^c,d   Corbalan, J Jose ^a   Faulkner, Colm ^a   Holmes, Justin D ^a,c   Tajber, Lidia ^a   Medina, Carlos ^a   Radomski, Marek Witold ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d NOTRE DAME UNIVERSITY   (Lebanon)

Author keywords

Gold nanoparticles; Inflammation; PEGylation; Platelet aggregation; Quartz crystal microbalance with dissipation

Indexed keywords

BIOCOMPATIBILITY; DIAGNOSIS; ENDOTHELIAL CELLS; FUNCTIONAL POLYMERS; MEDICAL APPLICATIONS; METAL NANOPARTICLES; PLATELETS; POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY;

GOLD NANOPARTICLES; INFLAMMATION; PEGYLATION; PLATELET AGGREGATION; QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION;

GOLD;

CITRATE SODIUM; GOLD NANOPARTICLE; MACROGOL; PEGYLATED GOLD NANOPARTICLE; THIOL; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONTROLLED STUDY; DISPERSION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IONIC STRENGTH; LIGHT SCATTERING; MOLECULAR INTERACTION; MOLECULAR STABILITY; MOLECULAR WEIGHT; PARTICLE SIZE; PH; PHASE CONTRAST MICROSCOPY; QUANTITATIVE ANALYSIS; QUARTZ CRYSTAL MICROBALANCE; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; CELLS, CULTURED; GOLD; HUMANS; METAL NANOPARTICLES; NANOCAPSULES; PARTICLE SIZE; PLATELET ACTIVATION; PLATELET AGGREGATION; POLYETHYLENE GLYCOLS;

EID: 84898476898     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1813     Document Type: Article

References (59)

1. C. Medina, M. J. Santos-Martinez, A. Radomski, O. I. Corrigan, and M. W. Radomski, Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150, 552 (2007).
2. Z. Magdolenova, A. Collins, A. Kumar, A. Dhawan, V. Stone, and M. Dusinska, Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology (2013), Epub ahead of print; PMID:23379603.
3. H. Johnston, G. Pojana, S. Zuin, N. R. Jacobsen, P. Møller, S. Loft, M. Semmler-Behnke, C. McGuiness, D. Balharry, A. Marcomini, H. Wallin, W. Kreyling, K. Donaldson, L. Tran, and V. Stone, Engineered nanomaterial risk. lessons learnt from completed nanotoxicology studies: Potential solutions to current and future challenges. Crit. Rev. Toxicol. 43, 1 (2013).
4. B. Y. Kim, J. T. Rutka, and W. C. Chan, Nanomedicine. N. Engl. J. Med. 363, 2434 (2010).
5. S. K. Libutti, G. F. Paciotti, A. A. Byrnes, H. R. Alexander, Jr, W. E. Gannon, M. Walker, G. D. Seidel, N. Yuldasheva, and L. Tamarkin, Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res. 16, 6139 (2010).
6. L. R. Hirsch, R. J. Stafford, J. A. Bankson, S. R. Sershen, B. Rivera, R. E. Price, J. D. Hazle, N. J. Halas, and J. L. West, Nanoshellmediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100, 13549 (2003).
7. D. P. O'Neal, L. R. Hirsch, N. J. Halas, J. D. Payne, and J. L. West, Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209, 171 (2004).
8. N. Khlebtsov and L. Dykman, Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647 (2011).
9. W. H. De Jong, W. I. Hagens, P. Krystek, M. C. Burger, A. J. Sips, and R. E. Geertsma, Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912 (2008).
10. C. M. Goodman, C. D. McCusker, T. Yilmaz, and V. M. Rotello, Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 15, 897 (2004).
11. Q. E. Fuentes, V. Andrés, O. M. Pello, J. F. de Mora, and G. I. Palomo, Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 24, 255 (2013).
12. M. J. Santos-Martínez, C. Medina, P. Jurasz, and M. W. Radomski, Role of metalloproteinases in platelet function. Thromb. Res. 121, 535 (2008).
13. M. J. Durand and D. D. Gutterman, Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation 20, 239 (2013).
14. J. J. Corbalan, C. Medina, A. Jacoby, T. Malinski, and M. W. Radomski, Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. Int. J. Nanomedicine 7, 631 (2012).
15. J. J. Corbalan, C. Medina, A. Jacoby, T. Malinski, and M. W. Radomski, Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: Inflammatory and cytotoxic effects. Int. J. Nanomedicine 6, 2821 (2011).
16. X. Li, A. Radomski, O. I. Corrigan, L. Tajber, F. De Sousa Menezes, S. Endter, C. Medina C, and M. W. Radomski, Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles. Nanomedicine 4, 735 (2009).
17. M. J. Santos-Martinez, I. Inkielewicz-Stepniak, C. Medina, K. Rahme, D. M. D'Arcy, D. Fox, J. D. Holmes, H. Zhang, and M. W. Radomski, The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation. Int. J. Nanomedicine 7, 243 (2012).
18. E. E. Connor, J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt, Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1, 325 (2005).
19. Y. Pan, S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, and W. Jahnen-Dechent, Size-dependent cytotoxicity of gold nanoparticles. Small 3, 1941 (2007).
20. J. M. Harris, N. E. Martin, and M. Modi, Pegylation: A novel process for modifying pharmacokinetics. Clin. Pharmacokinet. 40, 539 (2001).
21. M. J. Santos-Martinez, A novel method for the measurement of flow-induced platelet aggregation at nanoscale resolution level, Ph.D. Thesis, Trinity College Dublin (2009).
22. M. J. Santos-Martinez, C. Medina, A. Prina-Mello, J. Conroy, S. P. Samuels, Y. Volkov, and M. W. Radomski, A nanoscale resolution assay of flow-induced platelet microaggregation. Kardiochirurgia I Torakochirurgia Polska 7, 365 (2010).
23. E. A. Jaffe, R. L. Nachman, C. G. Becker, and C. R. Minick, Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745 (1973).
24. J. Turkevich, P. C. Stevenson, and J. A. Hillier, A study of the nucleation, and growth process in the synthesis of colloidal gold. Discuss. Faraday. Soc. 11, 55 (1951).
25. G. Frens, Controlled nucleation for regulation of particle-size in monodisperse gold suspensions. Nature-Phys. Sci. 241, 20 (1973).
26. J. Kimling, M. Maier, B. Okenve, V. Kotaidis, H. Ballot, and A. Plech, Turkevich method for gold nanoparticle synthesis revisited. J. Phys. Chem. B 110, 15700 (2006).
27. G. Sauerbrey, Verwendung von Schwingquarzen zur wägung dünner schichten und zur mikrowägung. Z. Phys. 155, 206 (1959).
28. K. A. Marx, Quartz crystal microbalance: A useful tool for studying thin polymer films and complex biomolecular systems at the solution-surface interface. Biomacromolecules 4, 1099 (2003).
29. M. Dixon, Quartz crystal microbalance with dissipation monitoring: Enabling real-time characterization of biological materials and their interactions. J. Biomol. Tech. 19, 151 (2008).
30. A. Nemmar, M. F. Hoylaerts, P. H. Hoet, and B. Nemery, Possible mechanisms of the cardiovascular effects of inhaled particles: Systemic translocation and prothrombotic effects. Toxicol. Lett. 149, 243 (2004).
31. A. Radomski, P. Jurasz, D. Alonso-Escolano, M. Drews, M. Morandi, T. Malinski, and M. W. Radomsk, Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 146, 882 (2005).
32. K. Donaldson, L. Tran, L. A. Jimenez, R. Duffin, D. E. Newby, N. Mills, W. MacNee, V. Stone, Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part. Fibre Toxicol. 2, 10 (2005).
33. M. Hu, J. Chen, Z. Y. Li, L. Au, G. V. Hartland, X. Li, M. Marquez, and Y. Xia, Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 35, 1084 (2006).
34. X. Huang, P. K. Jain, I. H. El-Sayed, and M. A. El-Sayed, Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 23, 217 (2008).
35. X. Huang, S. Neretina, and M. A. El-Sayed, Gold nanorods: From synthesis and properties to biological and biomedical applications. Adv. Mater. 21, 4880 (2009).
36. P. K. Jain, X. Huang, I. H. El-Sayed, and M. A. El-Sayed, Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 41, 1578 (2008).
37. N. G. Khlebtsov and L. A. Dykman, Optical properties and biomedical applications of plasmonic nanoparticles. J. Quant. Spectrosc. Radiat. 111, 1 (2010).
38. K. S. Lee and M. A. El-Sayed, Gold and silver nanoparticles in sensing and imaging: Sensitivity of plasmon response to size, shape, and metal composition. J. Phys. Chem. B 110, 19220 (2006).
39. H. W. Liao, C. L. Nehl, and J. H. Hafner, Biomedical applications of plasmon resonant metal nanoparticles. Nanomedicine 1, 201 (2006).
40. M. Scampicchio, A. Arecchi, and S. Mannino, Optical nanoprobes based on gold nanoparticles for sugar sensing. Nanotechnology 20, 135501 (2009).
41. G. F. Wang, A. S. Stender, W. Sun, and N. Fang, Optical imaging of non-fluorescent nanoparticle probes in live cells. Analyst 135, 215 (2010).
42. M. C. Daniel and D. Astruc, Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293 (2004).
43. S. Link and M. A. El-Sayed, Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J. Phys. Chem. B 103, 4212 (1999).
44. F. Gauffre, K. Rahme, J. D. Marty, B. Payre, and C. A. Mingotaud, Systematic study of the stabilization in water of gold nanoparticles by poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers. J. Phys. Chem. C 111, 7273 (2007).
45. K. Rahme, J. Oberdisse, R. Schweins, C. Gaillard, J. D. Marty, C. Mingotaud, and F. Gauffre, Pluronics-stabilized gold nanoparticles: Investigation of the structure of the polymer-particle hybrid. Chem. Phys. Chem. 9, 2230 (2008).
46. C. J. Murphy, T. K. Sau, A. M. Gole, C. J. Orendorff, J. Gao, L. Gou, S. E. Hunyadi, and T. Li, Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications. J. Phys. Chem. B 109, 13857 (2005).
47. J. M. Zook, V. Rastogi, R. I. MacCuspie, A. M. Keene, and J. Fagan, Measuring agglomerate size distribution and dependence of localized surface plasmon resonance absorbance on gold nanoparticle agglomerate size using analytical ultracentrifugation. ACS Nano 5, 8070 (2011).
48. V. M. Gun'ko, A. V. Klyueva, Y. N. Levchuk, and R. Leboda, Photon correlation spectroscopy investigations of proteins. Adv. Colloid. Interfac. 105, 201 (2003).
49. K. Rahme, T. Doody, A. K. Jain, L. Chen, M. Morris, C. O'Driscoll, and J. D. Holmes, Synthesis and stabilisation of poly(ethylene glycol)-coated gold nanoparticles for siRNA delivery. Biomed. Eng. Res. 1, 5 (2011).
50. N. Wangoo, C. R. Suri, and G. Shekhawat, Interaction of gold nanoparticles with protein: A spectroscopic study to monitor protein conformational changes. Appl. Phys. Lett. 92, 133104 (2008).
51. M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, and K. A. Dawson, Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 105, 14265 (2008).
52. N. B. Shah, G. M. Vercellotti, J. G. White, A. Fegan, C. R. Wagner, and J. C. Bischof, Blood-Nanoparticle interactions and in vivo biodistribution: Impact of surface PEG and ligand properties. Mol. Pharm. 9, 2146 (2012).
53. J. W. Hwang, H. S. Jung, and D. Y. Lee, Inhibition of platelet adhesion onto intrahepatically transplanted islets using PEGylation for attenuating instant blood-mediated inflammatory reaction (IBMIR). J. Control. Release. 152, 213 (2011).
54. D. Li, H. Chen, W. G. McClung, and J. L. Brash, Lysine-PEGmodified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis. Acta Biomater. 5, 1864 (2009).
55. J. S. Pober and W. C. Sessa, Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803 (2007).
56. J. Steffel, T. F. Luscher, and F. C. Tanner, Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications. Circulation 113, 722 (2006).
57. M. Romano, M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, W. Luini, V. van Hinsbergh, S. Sozzani, F. Bussolino, V. Poli, G. Ciliberto, and A. Mantovani, Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6, 315 (1997).
58. A. H. Sprague and R. A. Khalil, Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 78, 539 (2009).
59. E. Oh, J. B. Delehanty, K. E. Sapsford, K. Susumu, R. Goswami, J. B. Blanco-Canosa, P. E. Dawson, J. Granek, M. Shoff, Q. Zhang, P. L. Goering, A. Huston, and I. L. Medintz, Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cellpenetration peptides and particle size. ACS Nano 5, 6434 (2011).